Navigation Links
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Date:4/25/2008

tes a greatly increased risk of premature cardiovascular disease (CVD) and CVD-related death. In phase 2 studies, mipomersen, a weekly injectable therapeutic, was observed to reduce cholesterol and other atherogenic lipids beyond reductions achieved with standard lipid-lowering drugs.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 18 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Ibis Biosciences, Inc., Isis' majority-owned subsidiary, is developing and commercializing the Ibis T5000(TM) Biosensor System, a revolutionary system to identify infectious organisms. Isis is a joint owner of Regulus Therapeutics LLC, a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,500 issued patents worldwide. Additional information about Isis is available at http://www.isispharm.com.

ABOUT GENZYME

One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown from a small start-up to a diversified enterprise with more than 10,000 employees in locations spanning the globe and 2007 revenues of $3.8 billion. In 2007, Genzyme was chosen to receive the National Medal of Technology, the highest honor awarded by the President of the United States for technological innovation.

With many established products and services helping patients in nearly 90 countries, Genzyme
'/>"/>

SOURCE Genzyme Corp. and Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Lee Antimicrobial Solutions LLC (“LAMS”), the ... and a Leader in Environmental Disinfection Device Design, ... device developed for home use available for the ... DHP Technology, a revolutionary means to disinfect your ... bacteria, viruses, microbes and offensive odors. A technology ...
(Date:8/27/2014)... York (PRWEB) August 27, 2014 Power ... in U.S. courts on behalf of women who allegedly ... morcellation, Bernstein Liebhard LLP reports. According to court documents, ... August 18th in the U.S. District Court, Northern District ... who claims the use of a power morcellator manufactured ...
(Date:8/27/2014)... 2014 Picture, if you will, a detective ... but more of a Mr. Inside, a Doc Blanchard type, ... personalities and world view. This Mr. Inside was an internationally ... Austin, and Mr. Outside was an Austin Police Department lieutenant. ... girlfriend, and a gaggle of teenagers embarked on a mission ...
(Date:8/27/2014)... When Jagger was 20 years old and at ... that he credits as one of the most memorable phone ... she could set him up with a summer job; one ... that job, and he has now spent the past 22 ... he also worked in school boards, employment programs and youth ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 The newest ... PA on Monday, September 8, 2014. This new 15,000 ... that features three primary care practices and walk-in laboratory ... is a very exciting endeavor for Abington Health as ... and CEO, Abington Health. “Establishing a location in Lower ...
Breaking Medicine News(10 mins):Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 2Health News:A New York Based Company Announces The Release Of An Advanced, Environmentally Friendly Disinfection Technology For In-Home Use 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:UW Rankin Self-Publishes Debut Novel, Sublimity: Perchance to Dream, A Speculative Science Mystery 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Abington Health Opens New Health Center in Lower Gwynedd 2
... WASHINGTON, DC -- A study in the December issue of ... as to why death rates for less educated middle aged ... despite increased awareness and treatments aimed at reducing health disparities. ... with low education levelsthat is high school or lessare twice ...
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) -- Every ... rape, physical violence, or stalking by an intimate partner, according ... to data from the U.S. Centers for Disease Control and ... of partner violence each year, with by far the biggest ...
... 14 (HealthDay News) -- ,Headache affects 50 percent of HIV/AIDS ... are severe, a new study says. About 27.5 percent ... migraine," a rare condition in which a person has migraine ... days a month. This condition occurs in only 2 percent ...
... will have been diagnosed with locally-advanced pancreatic cancer in ... treatment option for these patients whose tumor has grown ... the past 20 years, numerous treatment regimens have been ... by chemoradiation being the current standard approach. However, the ...
... countries rely on traditional medicine as an accessible and ... scientific data has not existed to evaluate the potential ... the William L. Brown Center of the Missouri Botanical ... shrimp to determine the toxicity of 341 Northern Peruvian ...
... HealthDay Reporter , WEDNESDAY, Dec. 14 (HealthDay News) ... from sensing or reacting to anything happening to their ... recognizing a person sitting to that side -- may recover ... brain, Italian researchers report. This inability to process and ...
Cached Medicine News:Health News:Study takes aim at education-based death rate disparities 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 2Health News:Millions of Americans Are Victims of Sexual Violence: CDC 3Health News:Headaches May Plague Many With HIV/AIDS 2Health News:RTOG initiates a phase I trial testing the therapy ganitumab for locally advanced pancreatic cancer 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 2Health News:Missouri Botanical Garden scientists examine toxicity of medicinal plants in Peru 3Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 2Health News:Magnetic Brain Stimulation Might Help Some Stroke Patients 3
(Date:8/27/2014)... DIEGO , Aug. 27, 2014 Ambit Biosciences (Nasdaq: ... and development of drugs targeting unmet needs in oncology, autoimmune ... Baird 2014 Health Care Conference to be held at The ... on September 3-4, 2014. Alan ... Company and its lead drug candidate, quizartinib, at 1:10 p.m. ...
(Date:8/27/2014)... 27, 2014  After the February 2014 launch of ... solution for medical practices and management companies, Prime ... new software. "The feedback has been great," ... "The sheer number of demos and new sign-ups is ... for these types of software features." ...
(Date:8/27/2014)... 27, 2014  Zimmer Holdings, Inc. (NYSE and SIX: ... it will be participating in the Morgan Stanley 2014 ... New York, New York , on Tuesday, ... CEO of Zimmer, will be presenting at 9:10 a.m. ... of Biomet, will join Mr. Dvorak for the Q&A ...
Breaking Medicine Technology:Ambit Announces Participation At Baird 2014 Health Care Conference 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 2Medical Software Company, Prime Clinical Systems, Sees Excellent Response to their Workers' Compensation Solutions 3
... 9, 2012 Young Innovations, Inc. (NASDAQ – YDNT) ... quarterly dividend of $0.04 per share, payable June 15, ... 2012. Young Innovations develops, manufactures and markets ... assistants and consumers. The Company,s consumables product offering includes ...
... for WAISMANN METHOD® rapid opiate detox treatment ... support for National Fibromyalgia Awareness Day, taking place on ... are being prescribed opiate painkillers to address their chronic ... prescription painkiller use is also surging nationwide.  ...
Cached Medicine Technology:Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend 2WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day 2
... is the First and Only ... the powerful technology of RESTORE with ... to create the unrivaled RESTOREPRIME. The ... and coverage for managing patients with ...
The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite....
... Atlas II HF systems are intended to ... for automated treatment of life-threatening ventricular arrhythmias. ... Atlas II HF systems are also intended:, ... symptoms of moderate to severe heart failure ...
Medicine Products: